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THE EFFECTS OF IN UTERO LEVOTHYROXINE EXPOSURE ON ANTERIORPOSTERIOR CRANIOFACIAL DEVELOPMENT IN A MOUSE MODEL
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B.S., Psychology, Clemson University, 2008
D.M.D., Medical University of South Carolina, 2016

Introduction: The purpose of this study was to investigate the effects of in utero levothyroxine
exposure on anterior-posterior craniofacial development in a mouse model.
Methods: In order to determine the effects of in utero levothyroxine exposure on anteriorposterior craniofacial development, a study group (n=19) of C57BL6 mice were exposed to high
dose (~667ng per day) levothyroxine during fetal development. Mice were sacrificed day 15
post-natal. Skulls were fixed in a solution of 4% paraformaldehyde, then switched to 70%
ethanol in preparation for microCT imaging. Scans were loaded into Dolphin Imaging Software
and lateral cephalograms were rendered and analyzed.
Results: According to the Mann-Whitney U tests, statistically significant differences were found
in the maxillary position between the in utero levothyroxine exposed mice and the control mice
(p<0.001). The average maxillary position angular measurement in the control group was larger
at 112.19˚ (± 2.63) compared to the exposed group average of 107.25˚ (± 6.05). The exposure
group exhibited an average of 5˚ degree decrease in this measure, indicating a tendency for a
retrusive maxilla. This significant finding indicates that in utero thyroxine exposure can
predispose offspring to maxillary skeletal retrusion. Additionally, exposure did not result in
statistically significant changes to the mandible. While not a statistically significant finding, all
anterior-posterior average measurement lengths were smaller for the exposure group
compared to the control.
Conclusions: Overall, the data supports other research that maternal exogenous levothyroxine
exposure can cause aberrations in craniofacial jaw development. Excessive fetal levothyroxine
exposure can predispose offspring to variations in maxillary anterior-posterior position. In
humans, close monitoring of maternal thyroxine levels by primary care providers or
obstetricians-gynecologists maybe important to limit craniofacial developmental aberrations.

INTRODUCTION:
Five in 1000 pregnancies are complicated by hypothyroidism usually due to Hashimoto’s
thyroiditis, and one in 500 pregnancies suffer from hyperthyroidism, most commonly a result of
Graves’ disease.1 Both women supplementing thyroxine to treat hypothyroidism and women
with hyperthyroidism could be exposed to excessive levels of thyroxine during pregnancy.
Thyroid hormone plays an active role in the regulation of body metabolism and normal fetal
development. It is critical to normal bone and cartilage development. 2 Aberrant thyroid
hormone production has been linked to alterations in craniofacial development and
craniosynostosis since the 1970s. 2, 3,4,5,6 In mice exposed to higher levels of levothyroxine
during fetal development, studies have found increased metabolic levels at the cranial base
synchondrosis and accelerated bone formation due to increased IgF signaling and chondrocyte
hypertrophy.2 The active chondrogenesis occurring at cranial base synchondrosis as a side
effect of levothyroxine produces changes in the craniofacial skeleton. Maternal thyroxine
produces narrowed glenoid fossas, greater anterior rotation of the mandible and reduced size
of the coronoid process. 14 Aberrations in maternal thyroid hormone production are link to a
2.5-fold increased risk of craniosynostosis. 7, 8
Of particular importance, previously published research indicates the occurrence of
sutural narrowing and premature fusion after thyroid treatment. 2, 9 Thyroxine appears to alter
normal bone metabolism and predisposes growing mice to premature sutural fusion. A
previous study with the same mice sample used in this study, observed earlier cessation of
growth in calvarial length.11 This effect lead to compensatory growth of the sagittal suture and
an increase in cranial vault width in mice exposed to high dose thyroxine in utero, resulting in
an increased prevalence of brachyfacial phenotype. 10
Our null hypothesis states that there is no difference in anterior-posterior jaw
development between the in utero thyroxine exposed mice and the control group.
MATERIALS AND METHODS:
The mice used for this project were adult, wild type, C57BL6 (Mus musculus, Jackson
Laboratories, Bar Harbor, ME, USA) male and female. Animals were bred and separated at day
13 post-conception. At this time, the thyroxine dosage given as levothyroxine (Synthyroid) was
dispensed through daily drinking water of 3-5mL to the pregnant dams. Mice were exposed to
667ng/daily of thyroxine (high dose). Mouse pups were sacrificed via carbon dioxide overdose
or secondarily, cervical dislocation at day 15 postnatal. Skulls were collected and fixed with 4%
formaldehyde for 48 hours and then prepared with 70% ethanol for micro computed
tomography (µCT) analysis. Additional scans were collected for varying doses (no dose, low
dose and high dose) and at varying post-natal days (15, 20, and 25). These data were used in
the primary study. 15 days post-natal life was chosen for this orthodontic research since 15
days post-natal mice pup life span correlates with the adolescent age of most orthodontic
patients. The high dose mice exposure was chosen as it correlates to excessive levels of human
thyroxine, or greater than 200 to 300 mcg/day.

Animal use protocols were approved by Georgia Regents University Institutional Animal
Care and Use Committee (2011-0365), and the Medical University of South Carolina
Institutional Animal Care and Use Committee (AR#3341). All breeding procedures were carried
out in an Association for Assessment and Accreditation of Laboratory Animal Care International
accredited faculty, where all husbandry and related services are provided by the Division of
Laboratory Animal Resources. Animals were housed in ventilated racks with automatic water
dispensers and feeders providing mice with TEKLAD pellets with 12 hour light-dark cycles.
Certified technical personnel and registered veterinary technicians provided daily observation
and handling of lab animals. Signs of dehydration and pain as indicated by hunched and
lethargic behavior were monitored to assess animal health. All procedures and the reporting
thereof are in compliance with the Animal Research: Reporting in Vivo Experiments (ARRIVE)
guidelines.
Microcomputed tomography images were obtained on the 15 day post-natal mice skulls
with SkyScan 1174 (Kontich, Belgium) at 22.57 µm voxel resolution. 61 mixed sex scans were
used in this study (Control, n= 42, Exposure, n=19). Mice skulls were reconstructed with NRecon
v1.6.4.8 (BrukermicroCT, Kontich, Belgium) and imported into Amira v5.0 where it was exposed
to a Gaussian Smoothing image filter (r50.3 in X, Y and Z dimensions; isometric kernel size 53)
to decrease extraneous noise in the images. Images were then imported into Dolphin Software
(Dolphin Imaging 11.9 Premium, Los Angeles, California) and lateral cephalograms were
extracted for measurement analysis. In order to construct the two-dimensional images, the
three-dimensional images were oriented facing to the right of the screen and the occlusal plane
parallel to the floor. Ten landmarks were determined from a previously published study by
Simon et al (see chart below).13 Six measurements were analyzed for anterior-posterior
changes including palatal length (distance from Mu to Bu, measured in millimeters), maxillary
position (So-E-Pr angle, measured in degrees), mandibular length (distance from Co to Id,
measured in millimeters), ramus length (distance from Co to Gn, measured in millimeters),
corpus length (distance from Go to Id, measured in millimeters), and anterior mandibular
length (distance from Mn to Id, measured in millimeters). Measurements were collected by a
single, double-blinded rater (A.A.). A second rater traced the same control group to establish
inter-observer reliability (A.C.). This step insured accuracy in landmark identification between
raters and ensured easily repeatable landmarks.

Fig 1. 10 landmarks chosen for measurement of maxillary and mandible AP changes. See table
below for specific anatomical description of each landmark.
Table 1. Landmark anatomical definitions13
1. Bu: the most anterior and lower point of the lingual alveolar process of the incisal
bone
2. So: Intersection between the tympanic bulla and the posterior border of the
basisphenoid
3. E: intersection of frontal bone and most superior-anterior point of the posterior
limit to ethmoid bone
4. Id: the most anterior point of the vestibular mandibular alveolar process
5. Gn: lowest point of the ramus, or of the angular process
6. Co: point the highest of the condyle
7. Pr: the most anterior and lower point of the vestibular alveolar process of the incisal
8. Mu: the lowest point of the mesial alveolar process of the upper MI
9. Go: point of the most posterior of the gonial angle or of the angular process
10. Mn: A point in the deepest part of the antegonial notch curvature

Fig 2. Maxillary and mandibular measurements

STATISTICAL ANALYSIS
Independent sample T-Test or non-parametric alternative (Mann Whitney U) statistical
tests were conducted to examine any statistically significant differences between control and
exposed groups. Screening for normality was established via Shapiro Wilk testing. All data sets
were unable to be normalized. Therefore, the non-parametric Mann Whitney U test was
applied. Arithmetic mean and standard deviation values were measured for each data set.
When the P value was less than 0.05, the statistical test was considered a significant finding.
Two observers (A.A. and A.C) independently analyzed 17 of the control group samples to
establish inter-observer reliability. Pearson correlation testing was completed to verify interobserver accuracy with landmark identification within the control group. All values between
observers exhibited p-values less than .05. These results demonstrate reliable and repeatable
landmark identification between observers within the control groups. All statistical analyses
were completed using SPSS 23.0 (IBM, Armonk, NY, USA).

Table 2. Inter-Observer Data via Pearson Correlation
Variable
R- Value
Palatal Length
0.967
Maxillary position
0.577
Md length
0.836
Md Ramus Length
0.688
Md Corpus Length
0.960
Anterior Md Length
0.763

P-value
<0.001
0.019
<0.001
0.003
<0.001
0.001

RESULTS
Table 3. Group sample size of C57BL6 mice.
Control
High dose (~667 ng per day)

15 Day Mice
42
19

According to the Mann-Whitney U tests, statistically significant differences were found in the
maxillary position between the in utero levothyroxine exposed mice and the control mice
(p<0.001). The average maxillary position angular measurement in the control group was larger
at 112.19˚ (± 2.63) compared to the exposed group average of 107.25˚ (± 6.05). There was
approximately a 5˚ difference in the maxillary position measurement between the two groups.
Table 4 shows the arithmetic means and standard deviations for all anterior-posterior
measurements recorded as well as the results of the Mann-Whitney U Test.

Table 4. Mean values, standard deviation, and Mann-Whitney U Test results for each
anterior-posterior measurement.
Mean (Standard deviation)
Measurement
Control
Exposed
Mann-Whitney U
Test
(p-Value)
Palatal Length
4.18 (± 0.33)
4.14 (± 0.26)
0.262
Maxillary position
112.19 (± 2.63)
107.25 (± 6.05)
<0.001
Md length
9.05 (± 0.48)
8.89 (± 0.63)
0.365
Md Ramus Length
4.44 (±0.25)
4.36 (± 0.29)
0.217
Md Corpus Length
8.24 (± 0.55)
8.05 (± 0.63)
0.321
Anterior Md Length
5.50 (±0.31)
5.46 (± 0.43)
0.460
*Unit of linear values: millimeter (mm); Unit of angular values: degree (˚). Significant values are
written in italics.

Fig 3. Sample Micrograph with Dolphin Cephalometric Tracings
All measurement averages were slightly lower for the exposed group. However, no
statistically significant differences were noted for any of the additional anterior-posterior
measurements. On average, palatal length was 4.18mm (± 0.33) for the control group and
4.14mm (± 0.26) for the exposed group (p=0.262). On average, mandibular length was 9.05mm
(± 0.48) for the control group and 8.89mm (± 0.63) for the exposed group (p=0.365). Average
mandibular ramus length for the control group was 4.44mm (±0.25) and 4.36mm (± 0.29) for
the exposed group (p=0.217). Average mandibular corpus length was 8.24mm (± 0.55) for the
control group and 8.05mm (± 0.63) for the exposed group (p=0.321). Lastly, average anterior
mandibular length was 5.50mm (±0.31) and 5.46mm (± 0.43) for the exposed group (p=0.460).
Table 4 reveals the standard deviations and highlights the statistically significant findings. Figure
3 below demonstrates the lack of any statistically significant differences between exposed and
control groups. All measurements in the exposure group were only slightly smaller than the
control group.
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Fig 4. Average cephalometric linear measurements for exposed vs. control group

DISCUSSION
Overall, the data suggests there are no statistically significant differences in anteriorposterior jaw development measures between exposed and control groups, except in regards
to maxillary position. The null hypothesis was accepted in regards to palatal length, mandibular
length, mandibular ramus length, mandibular corpus length and anterior mandibular length.
The null hypothesis was rejected for maxillary position.

Fig 5. Comparison of Dolphin Micro CT Imaging and CT Slice of Control Group (on left)
and Exposure Group (on right).
The average maxillary position angular measurement in the control group was larger at
112.19˚ (± 2.63) compared to the exposed group average of 107.25˚ (± 6.05). There is
approximately a 5˚ difference in the maxillary position measurement between the two groups.
The maxillary position angular measurement is equivalent to the commonly used human
cephalometric measurement of SNA. The normal range for SNA is 813 for the average 9-yearold and 82 2 for adults. As the SNA increases above the normal range, it indicates a protrusive
maxilla. As the SNA decreases below the normal range, it indicates a retrusive maxilla. The
exposure group exhibited an average of 5˚ degree decrease in this measure, indicating a
tendency for a retrusive maxilla. This significant finding indicates that in utero levothyroxine
exposure can predispose offspring to maxillary skeletal retrusion.
Class three skeletal pattern could be worsened by additional effects of levothyroxine
found in other studies. Howie et al. reported early fusion of the coronal suture resulting in
compensatory growth of the sagittal suture and a brachycephalic phenotype in this same

mouse model.11 Increased osteogenesis was noted with premature sutural fusion. In mice
exposed to higher levels of levothyroxine as a fetus, Durham et al. found increased metabolic
levels at the cranial base synchondrosis and accelerated bone formation due to increased IgF
signaling and chondrocyte hypertrophy.2 These alterations resulted in a brachycephalic
phenotype with shortened bone length and decreased cranial base length in the high exposure
group.2 The maxilla grows down and forward due to translation and forces of the
synchondroses. With accelerated bone formation, the maxillary movement is more restricted.
This explanation is a possible theory for the alteration in maxillary angular position. Sutural
growth is more important in maxillary growth and development than in mandibular.
Due to lack of established vertical dimension, the limitations of this study include the
inability to conduct angular measurements to the mandible. Angular measurements equivalent
to the commonly used SNA could only be conducted in the maxilla. Prior studies have mounted
the mouse head in a cephalostat to establish a repeatable position in all three places of space.11
Future studies could mount the mice heads in a cephalostat to allow analysis of angular
measurements from cranial base to the mandibular landmarks and comparison to maxillary
angles. The anterior-posterior discrepancies could be established with equivalent analysis like
ANB and the Wits analysis. This study only evaluated anterior-posterior dimensions. Additional
studies could study transverse and vertical dimensions. A second limitation of the study was
difficulty in landmark identification of E point (intersection of frontal bone and most superioranterior point of the posterior limit to ethmoid bone). Maxillary position had the lowest interobserver correlation (R=0.577). Lastly, as technology develops three dimensional
superimpositions could prove even more accurate and valuable then two dimensional analysis.
With the rise of thyroid disorders throughout the world, the effects of exogenous
levothyroxine exposure in utero is important to understand. Recent literature shows the
significant effects of levothyroxine exposure on craniofacial and bone development. Our data
supports past studies that high dose levothyroxine does produce aberrant effects on
craniofacial development. This study provides support that in utero exposure to levothyroxine
can be a potential etiology for Class III skeletal malocclusions, specifically maxillary skeletal
retrusion. While levothyroxine supplementation may be necessary for maternal and fetal
health, close monitoring of dosage and blood serum levels should be performed to limit
craniofacial and developmental effects. It is important to understand the etiology of skeletal
abnormalities to allow for proper, efficient diagnosis and treatment.

CONCLUSIONS




High dose levothyroxine has an effect on craniofacial development.
High dose levothyroxine exposure in mice can predispose offspring to deficient anterior
maxillary growth with a tendency towards Class III skeletal patterns.
In humans, close monitoring of maternal thyroxine levels by primary care providers or
obstetricians-gynecologists maybe important to limit craniofacial developmental
aberrations.
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